You are here

Home » Content

Çocukluk çağında esansiyel hipertansiyon ve metabolik sendrom: Olgu sunumu

Primary hypertension and metabolic syndrome in childhood: a case report

Journal Name:

  • Türkiye Aile Hekimliği Dergisi

Publication Year:

  • 2011
DOI: 
doi:10.2399/tahd.11.187

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Childhood hypertension which differs from adults with its definition, etiology and management, is an important clinical problem. Primary (essential) hypertension is now identifiable in children and adolescents. Children and adolescents with primary hypertension are frequently overweight. Children who are overweight-obese and with arterial pressure greater than the 95th percentile need to be evaluated for other cardiovascular risk factors, lipid panel and glucose levels. Metabolic syndrome, defined as hypertension, central obesityincreased body mass index, dyslipidemia, insulin resistance-diabetes mellitus, is a cause of increased cardiovascular risk and diabetes. Here, a 7-year-old female patient with primary hypertension and metabolic syndrome is presented. Management of hypertension and metabolic syndrome in children require a comprehensive approach incorporating patient and family education, non-pharmacological measures and pharmacological treatments. For the diagnosis of hypertension, in every physical examination, arterial pressure measurement of children from the age of three should not be forgotten.
Bookmark/Search this post with
Abstract (Original Language): 
Çocukluk çağında hipertansiyon, etiyolojisi ve tedavisi erişkinlerden farklı olan önemli bir klinik sorundur. Günümüzde çocuk ve adolesanlarda da esansiyel hipertansiyon tanımlanmaktadır. Esansiyel hipertansiyonu olan çocuk ve adolesanlar sıklıkla fazla kiloludur. Tansiyon arteriyeli 95. persentil üzerinde olan kilolu-obez çocuklarda diğer kardiyovasküler risk faktörleri, lipid paneli ve glukoz düzeyi değerlendirilmelidir. Hipertansiyon, santral obezite-artmış vücut kitle indeksi, dislipidemi, insülin direnci-diyabetes mellitus ile tanımlanan metabolik sendrom; çocukluk döneminde artmış kardiyovasküler risk ve diyabet nedenidir. Burada, esansiyel hipertansiyon ve metabolik sendromu tanısı alan 7 yaşında kız çocuğu sunulmaktadır. Esansiyel hipertansiyon ve metabolik sendromu olan çocukların te¬ davisi; hasta ve aile eğitimi, nonfarmakolojik önlemler ve farmako¬ lojik tedavileri içeren ayrıntılı bir yaklaşım gerektirir. Hipertansiyon tanısı için çocuklarda üç yaşından itibaren tansiyon ölçümünün her fizik muayenede yapılması gerektiği unutmamalıdır.
FULL TEXT (PDF): 
PDF icon arastrmx_116859_15_pp_187-190.pdf
  • 4
187-190
  • Turkish

REFERENCES

References: 

1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in chil¬dren and adolescents. Pediatrics 2004;114(2 Suppl 4th Report):555-76.
2. Norwood VF. Hypertension. Pediatr Rev 2002;23:197-208.
3. Reaven GM. Banting Lecture1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
5. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation Part 1: Diagnosis and
Türkiye Aile Hekimliği Dergisi |
Turkish Journal of Family Practice | Cilt 15 | Sayı 4 | 2011
189
Classification of Diabetes Mellitus. World Health Organization Depertment of Noncommunicable Disease Surveillance Geneva. World Health Organization, 1999. http://www.staff.ncl.ac.uk/philip.home/ who_ dmc.htm#MetabSyndDef sayfasından 02/06/2011 tarihinde erişilmiştir.
6. Mancini MC. Metabolic syndrome in children and adolescents - criteria for diagnosis. Diabetol Metab Syndr 2009;1:20.
7. Akan H. Çocuk ve ergenlerde 4. rapora dayalı kan basıncı ölçümü ve değerlendirmesi. Turk Aile Hek Derg 2010;14:173-79.
8. Shulman GI. Cellular mechanism of insulin resistance. J Clin Invest
2000;160:171-6.
9. Gali-Tsinopoulou A, Karamouzis M, Nousia-Arvanitakis S. Insulin resist¬ance and hyperinsulinemia in pubertal obese children. J Pediatr Endocrinol
Metab 2003;16:555-60.
10. Weiss R, Dziura J, Burgert TS, ve ark. Obesity and the metabolic syn-
drom in children and adolescents. N Engl J Med 2004;350:2362-74.
11. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin
Endocrinol Metab 2004;89:2526-39.

Thank you for copying data from http://www.arastirmax.com